Current board rolesAurinia Pharmaceutical Inc.
Cardiome Pharma Corp.
ESSA Pharma Inc.
EducationBSc McGill University
Dr. Richard M. Glickman is one of Canada’s best known and most successful healthcare entrepreneurs. He is a co-founder and the chairman of Aurinia Pharma Corp., the founding Chairman of the Board of Essa Pharmaceuticals Inc., and is Chairman of the Board of Engene Inc. Previous roles include; co-founder, Chairman and CEO of Aspreva Pharmaceuticals and co-founder and CEO of StressGen Biotechnologies Corporation. Dr. Glickman also serves on the Boards of Vigil Health Solutions Inc and Cardiome Pharma Corp.
In addition to his corporate roles Richards has served on numerous biotechnology and community boards including Life Sciences B.C., the Canadian Genetic Disease Network, and the federal government’s National Biotechnology Advisory Committee. In 2004, Richard received the Ernst & Young Entrepreneur of the Year Award and British Columbia’s Top 40 under 40 Award for Entrepreneurs.
Dr. Glickman holds a B.Sc. in Microbiology and Immunology from the McGill University.